A medically supervised weight loss program conducted via online consultation with a physician.
Weight management using GLP-1 receptor agonists is supported through medication delivery to your hotel or accommodation during your stay in Japan.

This program is a physician-supervised medical weight loss program using GLP-1 receptor agonists. Through online consultations, doctors review patient questionnaires and provide weight management support from a medical perspective.

Even if in-person visits are difficult, medications can be delivered to your hotel or designated location during your stay in Japan.

All consultations are conducted online. Based on pre-consultation information, physicians assess your health status and medical history to determine eligibility. Treatment involves GLP-1 receptor agonists (such as Mounjaro), administered under medical supervision.

Designed for short-term international visitors, this program allows patients to manage their weight with medical support while staying in Japan. It provides a safe and properly managed medical weight loss approach under the supervision of a healthcare institution.

Providing Medical Institution

GOZEN Medical Corporation

〒060-0007
1-24, Nishi 24-chome, Kita 7-jo Chuo-ku, Sapporo

https://sapporo-goda.com

Specialty

• Orthopedic care
• Joint disorders (knee, shoulder, hip, etc.)
• Spine disorders (lower back pain, herniated disc, etc.)
• Sports injuries and sports-related conditions
• Chronic pain management
• Regenerative medicine
• AGA (hair loss) treatment
• Medical weight loss
• Musculoskeletal rehabilitation

Eligibility Criteria/Exclusions for Treatment

The following individuals are not eligible for this program: • Minors • Individuals aged 75 or older • Pregnant or planning pregnancy • Patients undergoing treatment for diabetes • Those with liver, gallbladder, pancreatic, or kidney diseases • Those with a history of major abdominal surgery • Those with a history of intestinal obstruction • Individuals with a BMI of 18 or lower • Those receiving treatment for psychiatric disorders • Those using medication for endocrine disorders • Individuals with steroid-induced obesity • Those with thyroid disorders • Patients with Multiple Endocrine Neoplasia Type 2 (MEN2) or a family history of it • Those with allergies to medications used in this treatment Treatment may be declined based on the physician’s judgment for safety reasons.

Remarks

【Program Introduction Videos】 https://youtu.be/r6pO0_S-pZ4 https://youtu.be/qu2Eyq57Sm8 【Treatment Flow】 This program is a fully online medical service. • Complete the pre-consultation questionnaire • Online consultation with a physician • Payment procedure (completed in advance via JTB) • Medication delivery to your hotel or designated address • Medication will be shipped if deemed appropriate after the online consultation

Precautions / Contraindications

• This treatment is not covered by public health insurance and is provided as a private medical service.
• Treatment outcomes may vary between individuals.
• Potential side effects and risks of medications will be explained by the physician during consultation.
• This treatment may not be eligible for the government relief system for adverse drug reactions.